tiprankstipranks
Advertisement
Advertisement

CVS Group CEO Richard Fairman to Retire After Steering Growth and Expansion

Story Highlights
  • CVS Group has expanded to about 475 practices and 9,000 staff, cementing its position as a leading UK-listed veterinary services provider with growing UK and Australian operations.
  • Chief executive Richard Fairman will retire after overseeing major growth, regulatory milestones and market upgrades, staying on until a successor is found to ensure a smooth transition.
  • Looking for the best stocks to buy? Follow the recommendations of top-performing analysts.
CVS Group CEO Richard Fairman to Retire After Steering Growth and Expansion

Claim 55% Off TipRanks

CVS Group plc ( (GB:CVSG) ) has provided an announcement.

CVS Group plc, the UK-listed veterinary services provider with a significant presence in both the UK and Australia, has grown rapidly in recent years, expanding its network to around 475 practices and nearly 9,000 employees while moving up to the Main Market of the London Stock Exchange and into the FTSE 250 index. The company has also strengthened its position through international expansion, development of a culture focused on clinical excellence, and diversification into diagnostics and online retail.

The board announced that Chief Executive Officer Richard Fairman plans to retire for personal reasons, after leading CVS through a period of substantial strategic progress, including the Australian expansion and a near tripling of EBITDA. Fairman will remain in post until a successor is appointed to ensure an orderly handover, and the board will commence an executive search, with the outgoing CEO highlighting a positive outlook for the group as acquisitions resume and regulatory uncertainty has eased.

The most recent analyst rating on (GB:CVSG) stock is a Hold with a £1233.00 price target. To see the full list of analyst forecasts on CVS Group plc stock, see the GB:CVSG Stock Forecast page.

Spark’s Take on CVSG Stock

According to Spark, TipRanks’ AI Analyst, CVSG is a Neutral.

The score is primarily supported by solid financial performance, led by strong free cash flow growth and improved leverage. This is meaningfully offset by weak technicals (broad downtrend despite oversold readings) and a relatively high P/E with a low dividend yield.

To see Spark’s full report on CVSG stock, click here.

More about CVS Group plc

CVS Group plc is a UK-listed veterinary group and leading provider of veterinary services with operations in the UK and Australia. The group runs around 475 veterinary practices, including specialist referral hospitals and out-of-hours sites, and also operates laboratories for diagnostic services and an online retail business under the Animed Direct brand. It employs about 9,000 staff, including roughly 2,500 veterinary surgeons and 3,300 nurses and patient care assistants, and is focused on delivering high-quality clinical care supported by dedicated clinical and support teams.

Average Trading Volume: 634,440

Technical Sentiment Signal: Sell

Current Market Cap: £794.2M

Find detailed analytics on CVSG stock on TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1